EDB initiates strategic dialogue with NIRDC to boost R&D in pharma sector

The Sri Lanka Export Development Board (EDB) initiated a constructive dialogue with the National Initiative for R&D Commercialization (NIRDC) to explore avenues of support for strengthening the Sri Lankan pharmaceutical sector through Research and Development.

- 

The meeting took place on July 7th at the EDB premises, with the participation of private sector representatives from the pharmaceutical industry, NIRDC, and EDB.

EDB Chairman Mangala Wijesinghe opened the discussion by outlining the measures taken to enhance export revenue, including the reactivation of the Export Development Council of Ministers (EDCM) after nearly three decades. He highlighted that the EDCM now provides a vital platform to address policy-level issues across sectors.

He further emphasized the growing importance of developing the pharmaceutical industry through research and Development and noted that the collaboration with NIRDC is a timely and strategic step toward long-term export growth in the sector.